BioSpace News Archive

BeiGene, Ltd. announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted a supplemental new drug application of BeiGene’s anti-PD-1 antibody tislelizumab in combination with chemotherapy for first-line treatment of patients with advanced non-squamous non-small cell lung cancer.

The growing prevalence of chronic diseases is leading to the high occurrence of chronic musculoskeletal pain, which is likely to create an upswing in the demand for tapentadol worldwide.

The global market for surgical microscope is gaining significantly from the increasing prevalence of various chronic diseases, such as cancer, where surgery is essential for the treatment.

At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs.

The global healthcare chatbots market is expected to rise remarkably owing to the rise in the usage of internet and increasing number of internet connectivity all around the world.

Theranostics is a new field of medicine which relies on targeted therapies to conduct specific targeted tests.

The vendor landscape of the global non-small cell lung cancer therapeutics market features the presence of a number of players, but was dominated by Genentech, a Roche company, which accounted for nearly 36% of the overall market in 2014, observes a recent report by Transparency Market Research.

Even in crisis situations, such as war and earthquake trucks, trailers, trains, aircraft and ships that provide medical attention to people in need, mobile hospital can be moved into any part of the world.

The International Atomic Energy Agency describes the process of radiation protection or radiation shielding as the protection of humans from the negative impact they may receive when exposed to harmful values of ionizing radiation.

Histone deacetylase inhibitors are chemical compounds that interfere with and inhibit histone deacetylases. Histone deacetylases inhibitors are a new class of anti-cancer agents.